Wegovy is a prescription medication used to treat obesity in adults. It contains semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist. GLP-1 receptor agonists are used to treat type 2 diabetes, but Wegovy is specifically approved for weight loss. According to the sources provided, there is no information suggesting that Wegovy cannot be used in conjunction with other medications.

However, it is important to note that any medication can interact with other medications, and it is important to discuss all medications and supplements with a healthcare provider before starting Wegovy or any other medication. In addition, Wegovy is not recommended for use in people with a personal or family history of medullary thyroid carcinoma or in people with multiple endocrine neoplasia syndrome type 2.

Overall, while there is no specific information suggesting that Wegovy cannot be used in conjunction with other medications, it is important to discuss all medications and supplements with a healthcare provider before starting Wegovy or any other medication.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/WEGOVY
[2] https://www.medicalnewstoday.com/articles/drugs-wegovy
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717485/